维普中文期刊产品整合服务
17篇 您的检索式:作者名="Mead AM"
    题名 作者 年代 出处 被引量
1Intermittent versus con- tinuous oxaliplatin and fluorepyrimidine combination chemotherapy for first - line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC trial 显示文摘Adams RA Meade AM Seymour MT 2011Lancet Oncol2011,12,7:1
2Toxicity associat- ed with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the Mrc conin trial experi- ence显示文摘Adams RA Meade AM Madi A 2009Br J Cancer2009,100,2:1
3Intermittent versus continuous oxaliplatin and f1uoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomized phase 3 MRC COIN trial显示文摘Adams RA Meade AM Seymour MT 2011Lancet Oncol2011,12,7:1
4Additive intraocular pres- sure lowering effect of various medications with latanoprost 显示文摘O'Connor DJ Martone JF Mead AM 2002Am J Ophthalmol2002,133,6:1
5Postoperative pain assessment tools in day surgery: literature review显示文摘Coil AM Ameen JRM Mead D 2004Journal of Advanced Nursing2004,46,2:1
6Postoperative pain assessmenttools in day surgery :literature review 显示文摘Coll AM Ameen J RM Mead D 2004Journal of Advanced Nursing2004,46,2:1
7Cooperation between the PDGF receptors in cardiac neural crest cell migration显示文摘Richarte AM Mead HB Tallquist MD 2007Dev Biol2007,306,2:1
8Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial显示文摘Adams RA Meade AM Seymour MT 2011Lancet Oncol2011,12,7:1
9Intermittent versus contin-uous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer:results of the ran-domised phase 3 MRC COIN trial显示文摘Adams RA Meade AM Seymour MT 0,,:1
10The genome of the Western clawed frog Xenopus tropicalis显示文摘Hellsten U Harland R M Gilchrist M J Hendrix D Jurka J Kapitonov V Ovcharenko I Putnam N H Shu S Taher L Blitz I L Blumberg B Dichmann D S Dubchak I Amaya E Detter J C Fletcher R Gerhard D S Goodstein D Graves T Grigoriev I V Grimwood J Kawashima T Lindquist E Lucas S M Mead P E Mitros T Ogino H Ohta Y Poliakov A V Pollet N Robert J Salamov A Sater A K Schmutz J Terry A Vize P D Warren W C Wells D Wills A Wilson R K Zimmerman L B Zorn AM Grainger R Grammer T Khokha M K Richardson P M Rokhsar D S 2010Science2010,328,5978:1
11Inter- mittent versus continuous oxaliplatin and fluoropyrimi- dine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial显示文摘Adams RA Meade AM Seymour MT 2011Ann Oncol2011,22,5:1
12Intermittent che- motherapy plus either intermittent or continuous cetux- imab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B) :a ran- domised phase 2 trial 显示文摘Wasan H Meade AM Adams R 2014Lancet Oncol2014,15,6:1
13Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetux- imab in the MRC COIN trial experience显示文摘Adams RA Meade AM Madi A 2009Br J Cancer2009,100,2:1
14Toxicity associatedwith combination oxaliplatin plus fluoropyr imidine with orwithout cetuximab in the MRC COIN trial experience显示文摘Adams RA Meade AM Madi A 2009BrJ Cancer2009,100,2:1
15Postoperative pain assessment tools in day surgery:literature review显示文摘Coll AM Ameen JR Mead D 2004J Adv Nurs2004,46,2:1
16The roles of handedness and stimulus asymmetry in aesthetic preference显示文摘Mead AM Mclaughlin JP 1992Brain Cogn1992,20,2:1
17A systematic review of rado mized controlled trials (RCTs) of EGFB-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC):Impact of K-ras status显示文摘Vale CL Tiemey JF Meade AM 0,,01:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费